Latest 10-Q quarterly reports

NorthEast Community Bancorp, Inc. reported a decrease in net income for the second quarter of 2026, driven by higher credit loss expenses and a slight decline in net interest income, though total assets grew.

Kestrel Group Ltd. reported a net loss for the second quarter of 2026, with increased operating expenses and legacy business challenges impacting financial results, despite growth in its Program Services segment.

XPEL, Inc. announced robust Q2 2026 results with significant revenue increases driven by paint protection and window film sales, alongside strategic investments in manufacturing capabilities.

Ivanhoe Electric Inc. reported its second quarter 2026 financial results, highlighting progress on the Santa Cruz Copper Project, divestment gains, and increased exploration expenditures.

Assured Guaranty Ltd. reported a decrease in net income for the second quarter and first six months of 2026 compared to the prior year, primarily due to foreign exchange losses and lower equity in investees, though the financial guaranty segment showed resilience.

First Citizens BancShares announced a significant increase in net income and deposits for the second quarter of 2026, driven by higher noninterest income and improved credit provisions.

First Seacoast Bancorp, Inc. reported a net income of $249,000 for the second quarter of 2026, a significant improvement from a net loss in the prior year period.

John Marshall Bancorp, Inc. announced a significant increase in net income and diluted EPS for the second quarter of 2026, driven by robust net interest income and improved operational efficiencies.

Atossa Therapeutics reported continued net losses and substantial doubt regarding its ability to continue as a going concern, despite advancements in its (Z)-endoxifen clinical trials and a recent capital raise.

Tredegar Corporation's Q2 2026 results show a significant increase in net income driven by robust performance in its Aluminum Extrusions segment, though the High Performance Films segment experienced a decline.

Matador Resources Company announced robust financial and operational performance for the second quarter of 2026, driven by increased oil production and strategic acquisitions.

DoubleVerify Holdings, Inc. announced Q2 2026 results with a 3% revenue increase to $193.8 million and a significant 74% rise in net income to $19.3 million year-over-year, alongside a pending acquisition by Neptune BidCo US Inc.

Clover Health Investments, Corp. announced a substantial increase in total revenues and a significant swing to net income for the six months ended June 30, 2026, driven by membership growth and improved per-member premiums.

Community Trust Bancorp, Inc. announced record earnings for the second quarter of 2026, driven by significant growth in net interest income and noninterest income.

Telephone and Data Systems, Inc. (TDS) announced its second quarter 2026 results, showcasing substantial gains from wireless spectrum license sales and improved performance at its Array subsidiary, while its TDS Telecom segment navigates market shifts.

Array Digital Infrastructure, Inc. (AD) reported a significant surge in net income and operating revenues for Q2 2026, primarily due to substantial gains from spectrum license sales and increased site rental income.

Alpha Metallurgical Resources, Inc. reported a net loss for the second quarter of 2026, with revenues declining year-over-year, impacted by lower sales volumes and market conditions.

Rapid Micro Biosystems reported increased revenue for the quarter ended June 30, 2026, but also a widening net loss, with operating expenses rising across the board.

Rocket Companies Inc. announced a substantial increase in net income and revenue for the second quarter of 2026, driven by robust mortgage origination and successful integration of recent acquisitions.

Cognition Therapeutics reports on its Q2 2026 financial results, highlighting ongoing clinical trial progress for zervimesine while facing continued operational losses and a need for future funding.

Ultralife Corporation reported improved gross margins and net income in Q2 2026 compared to the prior year, driven by favorable product mix and tariff refunds, with a record backlog of $117.5 million.

Minerva Neurosciences reports progress on its Phase 3 C19 trial for roluperidone, but faces significant financial challenges with a substantial accumulated deficit and ongoing operational losses.

Miami International Holdings, Inc. (MIAX) announced robust Q2 2026 results with total revenues up 18.3% year-over-year, driven by strong performance in its Options segment and contributions from the TISE acquisition.

Oklo Inc. reports significant progress in regulatory milestones for its Aurora powerhouse and isotope reactor, alongside a substantial increase in cash and marketable securities, while continuing to manage significant operating losses.

Fiserv, Inc. reported a 4% decrease in total revenue for Q2 2026 compared to the prior year, driven by lower product sales and data analytics revenue, while operating income saw a significant 40% decline.

Treace Medical Concepts reported a 4.2% revenue decrease in Q2 2026 compared to the prior year, alongside an increased net loss and ongoing litigation.

Mobility Global Inc. reported its second-quarter 2026 financial results following its separation from S&P Global, showing revenue growth and solid Adjusted EBITDA, alongside significant debt issuance.

Somnigroup International's Q2 2026 results show a 3.0% decrease in net sales to $1.82 billion, but operating income rose 12.1% to $201.7 million, driven by improved gross margins and cost management.

Kiora Pharmaceuticals, Inc. (KPRX) filed its Form 10-Q for the quarter ended June 30, 2026, detailing progress in its clinical-stage retinal disease programs, strategic collaborations, and financial position.

DraftKings Inc. reported a net loss of $67.6 million for the second quarter of 2026, a significant decrease from a net income of $157.9 million in the prior year, with revenue also declining.